Objective To estimate the impact of aging and diabetes on insulin sensitivity, beta-cell function, adipocytokines, and incretin production. Methods Hyperglycemic clamps, arginine tests and meal tolerance tests were performed in 50 non-obese subjects to measure insulin sensitivity (IS) and insulin secretion as well as plasma levels of glucagon, GLP-1 and GIP. Patients with diabetes and healthy control subjects were divided into the following groups: middle-aged type 2 diabetes (MA-DM), aged Type 2 diabetes (A-DM) and middle-aged or aged subjects with normal glucose tolerance (MA-NGT or A-NGT). Results IS, as determined by the homeostasis model assessment, glucose infusion rate, and oral glucose insulin sensitivity, was reduced in the aged and DM groups compared with MA-NGT, but it was similar in the MA-DM and A-DM groups. Insulinogenic index, first and second phase insulin secretion and the disposition indices, but not insulin response to arginine, were reduced in the aged and DM groups. Postprandial glucagon production was higher in MA-DM compared to MA-NGT. Whereas the GLP-1 production was reduced in A-DM, no differences between groups were observed in GIP production. Conclusions In non-obese subjects, diabetes and aging impair insulin sensitivity. Insulin production is reduced by aging, and diabetes exacerbates this condition. Aging associated defects superimposed diabetic physiopathology, particularly regarding GLP-1 production. On the other hand, the glucose-independent secretion of insulin was preserved. Knowledge of the complex relationship between aging and diabetes could support the development of physiopathological and pharmacological based therapies. © 2014 Published by Elsevier Inc.637922929Christensen, K., Doblhammer, G., Rau, R., Vaupel, J.W., Ageing populations: The challenges ahead (2009) Lancet, 3 (374), pp. 1196-1208Lu, F.P., Lin, K.P., Kuo, H.K., Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis (2009) PLoS One, 4, p. 4144Wild, S., Roglic, G., Green, A., Sicree, R., King, H., Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 (2004) Diabetes Care, 27, pp. 1047-1053Ning, F., Qiao, Q., Tuomilehto, J., Hammar, N., Ho, S.Y., Söderberg, S., Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? (2010) Diabetes Metab Res Rev, 26, pp. 245-253Scheen, A.J., Diabetes mellitus in the elderly: Insulin resistance and/or impaired insulin secretion? (2005) Diabetes Metab, , [Spec No 2:5S27-5S34]Palmer, J.P., Ensinck, J.W., Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients (1975) J Clin Endocrinol Metab, 41, pp. 498-503Chang, A.M., Halter, J.B., Aging and insulin secretion (2003) Am J Physiol Endocrinol Metab, 284, pp. 7-E12Iozzo, P., Beck-Nielsen, H., Laakso, M., Smith, U., Yki-Jarvinen, H., Ferrannini, E., Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance (1999) J Clin Endocrinol Metab, 84, pp. 863-868Stumvoll, M., Meyer, C., Kreider, M., Perriello, G., Gerich, J., Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans (1998) Metabolism, 47, pp. 1227-1232McConnell, J.G., Alam, M.J., O'Hare, M.M., Buchanan, K.D., Stout, R.W., The effect of age and sex on the response of enteropancreatic polypeptides to oral glucose (1983) Age Ageing, 12, pp. 54-62Elahi, D., Andersen, D.K., Muller, D.C., Tobin, J.D., Brown, J.C., Andres, R., The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus (1984) Diabetes, 33, pp. 950-957Macintosh, C.G., Andrews, J.M., Jones, K.L., Wishart, J.M., Morris, H.A., Jansen, J.B., Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility (1999) Am J Clin Nutr, 69, pp. 999-1006Ranganath, L., Sedgwick, I., Morgan, L., Wright, J., Marks, V., The ageing entero-insular axis (1998) Diabetologia, 41, pp. 1309-1313Korosi, J., McIntosh, C.H., Pederson, R.A., Demuth, H.U., Habener, J.F., Gingerich, R., Effect of aging and diabetes on the enteroinsular axis (2001) J Gerontol A Biol Sci Med Sci, 56, pp. 575-M579Meneilly, G.S., Ryan, A.S., Minaker, K.L., Elahi, D., The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin (1998) J Clin Endocrinol Metab, 83, pp. 2925-2932Elahi, D., McAloon-Dyke, M., Fukagawa, N.K., Meneilly, G.S., Sclater, A.L., Minaker, K.L., The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects (1994) Regul Pept, 51, pp. 63-74Standards of medical care in diabetes - 2012 (2012) Diabetes Care, 35 (SUPPL. 1), pp. 11-S63. , American Diabetes AssociationEndocrinology & Metabolism. Diabetes Trial Unit. HOMA Calculator, , http://www.dtu.ox.ac.uk/, Oxford Centre For Diabetes [Acessed Dec 2012]Mari, A., Pacini, G., Murphy, E., Ludvik, B., Nolan, J.J., A model-based method for assessing insulin sensitivity from the oral glucose tolerance test (2001) Diabetes Care, 24, pp. 539-548Mari, A., Schmitz, O., Gastaldelli, A., Oestrgaard, T., Nyholm, B., Ferrannini, E., Meal and oral glucose tests for assessment of β-cell function: Modeling analysis in normal subjects (2002) Am J Physiol Endocrinol Metab, 283, pp. 1159-E1166Ward, W.K., Bolgiano, D.C., McKnight, B., Halter, J.B., Porte, Jr.D., Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus (1984) J Clin Invest, 74, pp. 1318-1328Kahn, S.E., Prigeon, R.L., McCulloch, D.K., Boyko, E.J., Bergman, R.N., Schwartz, M.W., Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function (1993) Diabetes, 42, pp. 1663-1672Huang, E.S., Liu, J.Y., Moffet, H.H., John, P.M., Karter, A.J., Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study (2011) Diabetes Care, 34, pp. 1329-1336Meigs, J.B., Muller, D.C., Nathan, D.M., Blake, D.R., Andres, R., The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging (2003) Diabetes, 52, pp. 1475-1484Røder, M.E., Schwartz, R.S., Prigeon, R.L., Kahn, S.E., Reduced pancreatic B cell compensation to the insulin resistance of aging: Impact on proinsulin and insulin levels (2000) J Clin Endocrinol Metab, 85, pp. 2275-2280Meneilly, G.S., Eliott, T., Assessment of insulin sensitivity in older adults using the hyperglycemic clamp technique (1998) J Am Geriatr Soc, 46, pp. 88-91Radegran, G., Blomstrand, E., Saltin, B., Peak muscle perfusion and oxygen uptake in humans: Importance of precise estimates of muscle mass (1999) J Appl Physiol, 87, pp. 2375-2380Ferrannini, E., Vichi, S., Beck-Nielsen, H., Laakso, M., Paolisso, G., Smith, U., Insulin action and age. European Group for the Study of Insulin Resistance (EGIR) (1996) Diabetes, 45, pp. 947-953Coon, P.J., Rogus, E.M., Drinkwater, D., Muller, D.C., Goldberg, A.P., Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age (1992) J Clin Endocrinol Metab, 75, pp. 1125-1132Ahima, R.S., Connecting obesity, aging and diabetes (2009) Nat Med, 15, pp. 996-997Kahn, S.E., The relative contributions of insulin resistance and beta-cell dysfunction to the physiopathology of type 2 diabetes (2003) Diabetologia, 46, pp. 3-19Jensen, C.C., Cnop, M., Hull, R.L., Fujimoto, W.Y., Kahn, S.E., Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S (2002) Diabetes, 51, pp. 2170-2178. , Diabetes Association Gennid Study GroupFritsche, A., Madaus, A., Stefan, N., Tschritter, O., Maerker, E., Teigeler, A., Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans (2002) Diabetes, 51 (SUPPL. 1), pp. 234-S239Lund, A., Vilsbøll, T., Bagger, J.I., Holst, J.J., Knop, F.K., The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes (2011) Am J Physiol Endocrinol Metab, 300, pp. 1038-E1046Vardarli, I., Köthe, L.D., Holst, J.J., Deacon, C.F., Theodorakis, M., Meier, J.J., GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes. Mentis N (2011) Diabetes, 60, pp. 1270-1276Lynn, F.C., Pamir, N., Ng, E.H., McIntosh, C.H., Kieffer, T.J., Pederson, R.A., Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats (2001) Diabetes, 50, pp. 1004-1011Pernicova, I., Korbonitz, M., Metformin - Mode of action and clinical implications for diabetes and cancer (2014) Nat Rev Endocrinol, 10, pp. 143-156Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., Gerich, J.E., Metabolic effects of metformin in non-insulin-dependet diabetes mellitus (1995) N Engl J Med, 333, pp. 550-554Thondam, S.K., Cross, A., Cuthbertson, D.J., Wilding, J.P., Daousi, C., Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with type 2 diabetes mellitus (2012) Diabet Med, 29, pp. 205-e210Solis-Herrera, C., Triplitt, C., Garduno-Garcia, J.J., Adams, J., Defronzo, R.A., Cerosimo, E., Mehcanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes (2013) Diabetes Care, 36, pp. 2756-2762Lindsay, J.R., Duffy, N.A., McKillop, A.M., Ardill, J., Óharte, F.P.M., Flatt, P.R., Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes (2005) Diabet Med, 22, pp. 654-657Cuthbertson, J., Patterson, S., Óharte, F.P.M., Bell, P.M., Investigation of the effect of oral metformin in dipeptidylpeptidase-4 (DPP-4) activity in type 2 diabetes (2009) Diabet Med, 26, pp. 649-654Inouye, S.K., Studenski, S., Tinetti, M.E., Kuchel, G.A., Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept (2007) J Am Geriatr Soc, 55, pp. 780-791Knowler, W.C., Fowler, S.E., Hamman, R.F., Christophi, C.A., Hoffman, H.J., 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) Lancet, 374, pp. 1677-1686. , Prevention Program Research Group